Skip to content

AI in Drug Discovery & Development

By Sara Mallatt, Director of Healthcare Research and Sean Carmichael

Hype, Reality, and What Comes Next

AI has emerged as a powerful potential solution that could revolutionize how drugs are discovered, developed, and brought to patients. AlphaSense recently hosted an expert call with Dr. Paul Agapow, Former Director of Data Science at GSK, to discuss how AI is making inroads in this area.

Drawing from the call with Dr. Agapow, the latest data, and additional expert insights, this report covers how AI is performing against high expectations, what’s working, and what's not. This report also dissects the competitive arena, covering both today’s key players and the mergers, acquisitions, and collaborations that are defining the future.

About the Authors
  • Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.
  • Sean Carmichael

    Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.

Explore more

The VC Playbook: How to Spot a Purple Cow in Crowded Pastures

In this playbook, we leverage insights from Harry Stebbings of 20VC to answer this question among others, including: What are the characteristics of successful early stage companies? Which unconventional criteria play an important role in securing deals?
Title slide for 'The Venture Capital Playbook: How to Spot a Purple Cow in Crowded Pastures,' featuring outlined illustrations of a purple cow and a white bull.

Execution in Focus: Tracking Key Healthcare and Biopharma Trends in 2026

This report tackles these issues and other key trends shaping the healthcare landscape in early 2026.
Title slide: Tracking Key Healthcare and Biopharma Trends in 2026 by Sara Mallatt and Sean Carmichael, featuring data graphs and medical icons.

Top AI Use Cases for Investment Banking

In this report, we explore how AI is transforming IB workflows by streamlining and accelerating intelligence and insights at scale.
Blue graphic for an article titled 'Top AI Use Cases For Investment Banking,' featuring white blueprint-style outlines of a skyscraper, dollar sign, and euro symbol on a grid.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.